AZ'6421

Cat. No.: IBDI-432313

AZ'6421 acts as Protcolysis Targeting Chimera (PROTAC) to selectively degrade estrogen receptor alpha. AZ'6421 has a potent anti-tumour effect to inhibit the uncontrolled cellular proliferation which arises from malignant disease. AZ'6421 can be used for the research of cancer such as breast cancer.

Product Details

Target	Estrogen Receptor/ERR | PROTACs
Molecular Weight	975.17
SMILES	C[[email protected]@H](N1CC(C)(F)C)CC2=C(NC3=C2C=CC=C3)[[email protected]]1C4=C(F)C=C(OCCCOCCCOCC(N[[email protected]@H](C(C)(C)C)C(N5[[email protected]](C(NCC6=CC=C(C7=C(C)N=CS7)C=C6)=O)C[[email protected]@H](O)C5)=O)=O)C=C4F

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.